INTERNATIONAL PATENT: ROCHE DIAGNOSTICS GMBH FILES APPLICATION FOR "TWO NOVEL FUSION TRANSCRIPTS FOR EARLY DETECTION OF NON-SMALL-CELL LUNG CANCER (NSCLC)"

GENEVA, Aug. 10 -- ROCHE DIAGNOSTICS GMBH (Sandhofer StraBe 11668305 Mannheim) filed a patent application (PCT/EP2024/087902) for "TWO NOVEL FUSION TRANSCRIPTS FOR EARLY DETECTION OF NON-SMALL-CELL LUNG CANCER (NSCLC)" on Dec 20, 2024. With publication no. WO/2025/162665, the details related to the patent application was published on Aug 07, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HABBEN, Kai (c/o Roche Diagnostics GmbHNonnenwald 282377 Penzberg), HUMMEL, Barbara Theresia (c/o Roche Diagnostics GmbHNonnenwald 282377 Penzberg), KASTNER, Peter (c/o Roche Diagnostics GmbHNonnenwald 2823...